3B/BMC scores patent victory
LAKE WALES, Fla. – 3B/BMC Medical has successfully invalidated a ResMed patent on a “cushion for patient interface” in China, it announced today. BMC in October initiated proceedings before the Chinese Patent Re-examination Board against five ResMed patents. BMC is also in the process of preparing IPR (Inter Partes Review) applications seeking to invalidate several ResMed patents in the U.S. Patent and Trademark Office. In April, the two companies concluded a trial before the International Trade Commission that was the result of a complaint filed by ResMed alleging infringement on several patents. A final decision is expected in December.